Homocysteine-mediated cholesterol efflux via ABCA1 and ACAT1 DNA methylation in THP-1 monocyte-derived foam cells

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 3, 2013, Pages 220-228

  Liang, Yu ^a   Yang, Xiaoling ^a   Ma, Linna ^b   Cai, Xin ^a   Wang, Lei ^a   Yang, Cheng ^a   Li, Guizhong ^a   Zhang, Minghao ^a   Sun, Weiwei ^a   Jiang, Yideng ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b People's Hospital of Ningxia Hui   (China)

Author keywords

acyl coenzyme A:cholesterol acyltransferase 1; ATP binding cassette transporter A1; cholesterol efflux; DNA methylation; homocysteine

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ACAT1 PROTEIN, HUMAN; ACETYL COENZYME A ACETYLTRANSFERASE; CHOLESTEROL; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; HOMOCYSTEINE; MESSENGER RNA; PHOSPHOLIPID;

ARTICLE; CELL LINE; CYTOLOGY; DNA METHYLATION; DOSE RESPONSE; FOAM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; LIPID METABOLISM; METABOLISM; MONOCYTE; RISK FACTOR;

ACETYL-COA C-ACETYLTRANSFERASE; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CHOLESTEROL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOAM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOMOCYSTEINE; HUMANS; LIPID METABOLISM; MONOCYTES; PHOSPHOLIPIDS; RISK FACTORS; RNA, MESSENGER;

EID: 84874383095     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms119     Document Type: Article

References (43)

1. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 2007, 4: 143-150.
2. Esteller M. CpG island methylation and histone modifications: biology and clinical significance. Ernst Schering Res Found Workshop 2006, 57: 115-126.
3. Hiltunen MO, Turunen MP, Häkkinen TP, Rutanen J, Hedman M, Mäkinen K and Turunen AM, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002, 7: 5-11.
4. Jones PA and Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3: 415-428.
5. Mayer W, Niveleau A, Walter J, Fundele R and Haaf T. Demethylation of the zygotic paternal genome. Nature 2000, 403: 501-502.
6. Torra IP, Chinetti G, Duval C, Fruchart JC and Staels B. Peroxisome proliferatoractivated receptors: from transcriptional control to clinical practice. Curr Opin Lipidol 2001, 12: 245-254.
7. Luciani MF, Denizot F, Savary S, Mattei MG and Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 1994, 21: 150-159.
8. Takata Y, Chu V, Collins AR, Lyon CJ, Wang W, Blaschke F and Bruemmer D, et al. Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II. Circ Res 2005, 97: e88-e96.
9. Neufeld EB, Demosky SJ, Jr, Stonik JA, Combs C, Remaley AT, Duverger N and Santamarina-Fojo S, et al. The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem Biophys Res Commun 2002, 297: 974-979.
10. Wang N, Silver DL, Thiele C and Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 2001, 276: 23742-23747.
11. Joyce C, Freeman L, Brewer HB, Jr and Santamarina-Fojo S. Study of ABCA1 function in transgenic mice. Arterioscler Thromb Vasc Biol 2003, 23: 965-971.
12. Basso F, Freeman L, Knapper CL, Remaley A, Stonik J, Neufeld Eb and Tansey T, et al. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J Lipid Res 2003, 44: 296-302.
13. Oram JF and Vaughan AM. ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res 2006, 99: 1031-1043.
14. Oram JF and Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005, 85: 1343-1372.
15. Guay SP, Brisson D, Munger J, Lamarche B, Gaudet D and Bouchard L. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics 2012, 7: 464-472.
16. Rudel LL, Lee RG and Cockman TL. Acyl coenzyme A:cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr Opin Lipidol 2001, 12: 121-127.
17. Chang TY, Chang CC, Lin S, Yu C, Li BL and Miyazaki A. Roles of acylcoenzyme A:cholesterol acyltransferase-1 and-2. Curr Opin Lipidol 2001, 12: 289-296.
18. Joyce C, Skinner K, Anderson RA and Rudel LL. Acyl-coenzyme A: cholesteryl acyltransferase 2. Curr Opin Lipidol 1999, 10: 89-95.
19. Warner GJ, Stoudt G, Bamberger M, Johnson WJ and Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem 1995, 270: 5772-5778.
20. Vaziri ND, Navab M and Fogelman AM. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol 2010, 6: 287-296.
21. Bell TA, III, Brown JM, Graham MJ, Lemonidis KM, Crooke RM and Rudel LL. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor2/2 mice. Arterioscler Thromb Vasc Biol 2006, 26: 1814-1820.
22. Hongo S, Watanabe T, Arita S, Kanome T, Kageyama H, Shioda S and Miyazaki A. Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages. Am J Physiol Endocrinol Metab 2009, 297: E474-E482.
23. Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J and Yang F, et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res 2006, 99: 598-606.
24. Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A and Sengupta S. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 2006, 5: 1.
25. McCully KS, Olszewski AJ and Vezeridis MP. Homocysteine and lipid metabolism in atherogenesis: effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide. Atherosclerosis 1990, 83: 197-206.
26. Wada Y, Sugiyama A, Yamamoto T, Naito M, Noguchi N, Yokoyama S and Tsujita M, et al. Lipid accumulation in smooth muscle cells under LDL loading is independent of LDL receptor pathway and enhanced by hypoxic conditions. Arterioscler Thromb Vasc Biol 2002, 22: 1712-1719.
27. Allain CC, Poon LS, Chan CS, Richmond W and Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20: 470-475.
28. Yang L, Yang JB, Chen J, Yu GY, Zhou P, Lei L and Wang ZZ, et al. Enhancement of human ACAT1 gene expression to promote the macrophagederived foam cell formation by dexamethasone. Cell Res 2004, 14: 315-323.
29. Jiang YD, Sun T, Zhang HP, Xiong JT, Cao J, Li GZ and Wang SR. Folate and ApoE DNA methylation induced by homocysteine in human monocytes. DNA Cell Biol 2007, 26: 737-744.
30. Du X, Han L, Guo AY and Zhao Z. Features of methylation and gene expression in the promoter-associated CpG islands using human methylome data. Comp Funct Genomics 2012, 2012: 598987.
31. Dhe-Paganon S, Syeda F and Park L. DNA methyl transferase 1: regulatory mechanisms and implications in health and disease. Int J Biochem Mol Biol 2011, 2: 58-66.
32. Clements EG, Mohammad HP, Leadem BR, Easwaran H, Cai Y, Van Neste L and Baylin SB. DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes. Nucleic Acids Res 2012, 40: 4334-4346.
33. Spady DK. Reverse cholesterol transport and atherosclerosis regression. Circulation 1999, 100: 576-578.
34. Iizuka M, Ayaori M, Uto-Kondo H, Yakushiji E, Takiguchi S, Nakaya K and Hisada T, et al. Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages. J Nutr Sci Vitaminol (Tokyo) 2012, 58: 96-104.
35. Miyazaki A, Sakashita N, Lee O, Takahashi K, Horiuchi S, Hakamata H and Morganelli PM, et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler Thromb Vasc Biol 1998, 18: 1568-1574.
36. Dove DE, Su YR, Zhang W, Jerome WG, Swift LL, Linton MF and Fazio S. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. Arterioscler Thromb Vasc Biol 2005, 25: 128-134.
37. Tabas I, Lim S, Xu XX and Maxfield FR. Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages. J Cell Biol 1990, 111: 929-940.
38. Ji ZS, Dichek HL, Miranda RD and Mahley RW. Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem 1997, 272: 31285-31292.
39. Qayum I and Ashraf M. Dna methyltransferase 1 (DNMT1) gene activity in human lymphomas correlates with aberrant p53 gene expression. J Ayub Med Coll Abbottabad 2006, 18: 1-6.
40. Wachsman JT. DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Mutat Res 1997, 375: 1-8.
41. Lee PJ, Washer LL, Law DJ, Boland CR, Horon IL and Feinberg AP. Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci USA 1996, 93: 10366-10370.
42. Davis CD and Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 2004, 229: 988-995.
43. Strain JJ, Dowey L, Ward M, Pentieva K and McNulty H. B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc 2004, 63: 597-603.